8-K
Current Report
MoonLake Immunotherapeutics Filed Acc 0001628280-23-023905
Material agreement · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading mltx-20230627.htm…